Skip to main content
Top
Published in: Current Geriatrics Reports 4/2018

01-12-2018 | Dermatology and Wound Care (C Sayed and D Culton, Section Editors)

Skin Disease and Neurological Conditions of the Elderly

Authors: John Tanaka, Christopher Henderson, Matilda W. Nicholas

Published in: Current Geriatrics Reports | Issue 4/2018

Login to get access

Abstract

Purpose of Review

Summarize and review the body of literature associating neurological diseases of the elderly with cutaneous disease.

Recent Findings

A growing body of evidence supports a close association between Parkinson’s disease and seborrheic dermatitis or rosacea, as well as a higher risk of melanoma. Development of bullous pemphigoid has also been found to be at higher incidence in those with multiple sclerosis. In some cases, skin disease may suggest early diagnosis of a developing neurologic condition, while in others, presence of a neurologic condition should prompt careful evaluation for cutaneous disease.

Summary

Elderly patients with neurodegenerative conditions should prompt evaluation for both benign facial dermatologic disease and bullous disease. Further research might elicit antigenic cross-reactivity between CNS epitopes and those in the skin.
Literature
1.
go back to reference Hurko O, Provost TT. Neurology and the skin. J Neurol Neurosurg Psychiatry. 1999;66:417–30.CrossRef Hurko O, Provost TT. Neurology and the skin. J Neurol Neurosurg Psychiatry. 1999;66:417–30.CrossRef
2.
go back to reference Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2917–223. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2917–223.
3.
go back to reference Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, et al. Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003;157:1015–22.CrossRef Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, et al. Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003;157:1015–22.CrossRef
4.
go back to reference Galvan A, Wichmann T. Pathophysiology of Parkinsonism. Clin Neurophysiol. 2008;119(7):1459–74.CrossRef Galvan A, Wichmann T. Pathophysiology of Parkinsonism. Clin Neurophysiol. 2008;119(7):1459–74.CrossRef
5.
go back to reference Ravn A-H, Thyssen JP, Egeberg A. Skin disorders in Parkinson’s disease: potential biomarkers and risk factors. Clin Cosmet Investig Dermatol. 2017;10:87–92.CrossRef Ravn A-H, Thyssen JP, Egeberg A. Skin disorders in Parkinson’s disease: potential biomarkers and risk factors. Clin Cosmet Investig Dermatol. 2017;10:87–92.CrossRef
6.
go back to reference de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5:525–35.CrossRef de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5:525–35.CrossRef
7.
go back to reference Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009;8:464–74.CrossRef Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009;8:464–74.CrossRef
8.
go back to reference Gregory R, Miller S. Parkinson’s disease and the skin. Pract Neurol. 2015;15:246–9.CrossRef Gregory R, Miller S. Parkinson’s disease and the skin. Pract Neurol. 2015;15:246–9.CrossRef
9.
go back to reference Gupta AK, Madzia SE, Batra R. Etiology and management of seborrheic dermatitis. Dermatology. 2004;208:89–93.CrossRef Gupta AK, Madzia SE, Batra R. Etiology and management of seborrheic dermatitis. Dermatology. 2004;208:89–93.CrossRef
10.
go back to reference Arsic Arsenijevic VS, Milobratovic D, Barac AM, Vekic B, Marinkovic J, Kostic VS. A laboratory-based study on patients with Parkinson’s disease and seborrheic dermatitis: the presence and density of Malassezia yeasts, their different species and enzymes production. BMC Dermatol. 2014;14:5.CrossRef Arsic Arsenijevic VS, Milobratovic D, Barac AM, Vekic B, Marinkovic J, Kostic VS. A laboratory-based study on patients with Parkinson’s disease and seborrheic dermatitis: the presence and density of Malassezia yeasts, their different species and enzymes production. BMC Dermatol. 2014;14:5.CrossRef
11.
go back to reference Braak H, Del Tredici K. Non-dopaminergic pathology of Parkinson’s disease. In: Olanow CW, Stocchi F, Lang AE, editors. Parkinson’s disease; 2011. Braak H, Del Tredici K. Non-dopaminergic pathology of Parkinson’s disease. In: Olanow CW, Stocchi F, Lang AE, editors. Parkinson’s disease; 2011.
12.
go back to reference • Tanner C, Albers K, Goldman S, Fross R, Leimpeter A, Klingman J, et al. Seborrheic dermatitis and risk of future Parkinson’s disease (PD)(S42. 001). Neurology. 2012;78(1 Supplement):S42–001 Retrospective review study which demonstrates that diagnosis of seborrheic dermatitis can precede and signal eventual diagnosis of Parkinson’s disease. • Tanner C, Albers K, Goldman S, Fross R, Leimpeter A, Klingman J, et al. Seborrheic dermatitis and risk of future Parkinson’s disease (PD)(S42. 001). Neurology. 2012;78(1 Supplement):S42–001 Retrospective review study which demonstrates that diagnosis of seborrheic dermatitis can precede and signal eventual diagnosis of Parkinson’s disease.
13.
go back to reference Burton JL, Cartlidge M, Cartlidge NEF, Shuster S. Sebum excretion in Parkinsonism. Br J Dermatol. 1973;88:263–6.CrossRef Burton JL, Cartlidge M, Cartlidge NEF, Shuster S. Sebum excretion in Parkinsonism. Br J Dermatol. 1973;88:263–6.CrossRef
14.
go back to reference Burton JL, Shuster S. Effect of L-Dopa on seborrhœa of Parkinsonism. Lancet. 1970;2(7662):19–20.CrossRef Burton JL, Shuster S. Effect of L-Dopa on seborrhœa of Parkinsonism. Lancet. 1970;2(7662):19–20.CrossRef
15.
go back to reference Cowley NC, Farr RM, Shuster S. The permissive effect of sebum in seborrhoeic dermatitis: an explanation of the rash in neurological disorders. Br J Dermatol. 1990;122:71–6.CrossRef Cowley NC, Farr RM, Shuster S. The permissive effect of sebum in seborrhoeic dermatitis: an explanation of the rash in neurological disorders. Br J Dermatol. 1990;122:71–6.CrossRef
17.
go back to reference Steinhoff M, Buddenkotte J, Aubert J, et al. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15:2–11.CrossRef Steinhoff M, Buddenkotte J, Aubert J, et al. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15:2–11.CrossRef
18.
go back to reference Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Exploring the association between rosacea and Parkinson disease: a Danish nationwide cohort study. JAMA Neurol. 2016;73(5):529–34.CrossRef Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Exploring the association between rosacea and Parkinson disease: a Danish nationwide cohort study. JAMA Neurol. 2016;73(5):529–34.CrossRef
19.
go back to reference Lyon S, Majewski S, Guido N, Ibler E, Huynh T, Rangel S, et al. LB766 Parkinson’s disease association with rosacea: a large, single center, retrospective study. J Investig Dermatol. 2016;136:B3.CrossRef Lyon S, Majewski S, Guido N, Ibler E, Huynh T, Rangel S, et al. LB766 Parkinson’s disease association with rosacea: a large, single center, retrospective study. J Investig Dermatol. 2016;136:B3.CrossRef
20.
go back to reference Mathieu RJ, Guido N, Ibler E, Serrano L, Rangel SM, Schlosser BJ, et al. Rosacea and subsequent diagnosis for Parkinson’s disease: a large, urban, single center, US patient population retrospective study. J Eur Acad Dermatol Venereol. 2018;32(4):e141–4.CrossRef Mathieu RJ, Guido N, Ibler E, Serrano L, Rangel SM, Schlosser BJ, et al. Rosacea and subsequent diagnosis for Parkinson’s disease: a large, urban, single center, US patient population retrospective study. J Eur Acad Dermatol Venereol. 2018;32(4):e141–4.CrossRef
21.
go back to reference Chen X, Feng D, Schwarzschild MA, Gao X. Red hair, MC1R variants, and risk for Parkinson’s disease–a meta-analysis. Ann Clin Transl Neurol. 2017;4(3):212–6.CrossRef Chen X, Feng D, Schwarzschild MA, Gao X. Red hair, MC1R variants, and risk for Parkinson’s disease–a meta-analysis. Ann Clin Transl Neurol. 2017;4(3):212–6.CrossRef
22.
23.
go back to reference Rastrelli M, Tropea S, Rossi CR, Alaibac M. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo. 2014;28:1005–11.PubMed Rastrelli M, Tropea S, Rossi CR, Alaibac M. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo. 2014;28:1005–11.PubMed
24.
go back to reference Liu R, Gao X, Lu Y, Chen H. Meta-analysis of the relationship between Parkinson disease and melanoma. Neurology. 2011;76(23):2002–9.CrossRef Liu R, Gao X, Lu Y, Chen H. Meta-analysis of the relationship between Parkinson disease and melanoma. Neurology. 2011;76(23):2002–9.CrossRef
25.
go back to reference Bertoni JM, Arlette JP, Fernandez HH, Fitzer-Attas C, Frei K, Hassan MN, et al. Increased melanoma risk in Parkinson disease: a prospective clinicopathological study. Arch Neurol. 2010;67(3):347–52.CrossRef Bertoni JM, Arlette JP, Fernandez HH, Fitzer-Attas C, Frei K, Hassan MN, et al. Increased melanoma risk in Parkinson disease: a prospective clinicopathological study. Arch Neurol. 2010;67(3):347–52.CrossRef
26.
go back to reference Gao X, Simon KC, Han J, Schwarzschild MA, Ascherio A. Genetic determinants of hair color and Parkinson’s disease risk. Ann Neurol. 2009;65:76–82.CrossRef Gao X, Simon KC, Han J, Schwarzschild MA, Ascherio A. Genetic determinants of hair color and Parkinson’s disease risk. Ann Neurol. 2009;65:76–82.CrossRef
27.
go back to reference Pan T, Zhu J, Hwu W-J, Jankovic J. The role of α-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells. PLoS One. 2012;7:e45183.CrossRef Pan T, Zhu J, Hwu W-J, Jankovic J. The role of α-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells. PLoS One. 2012;7:e45183.CrossRef
28.
go back to reference Pfeiffer RF. Management of autonomic dysfunction in Parkinson’s disease. Semin Neurol. 2017;37(02):176–85 Thieme Medical Publishers.CrossRef Pfeiffer RF. Management of autonomic dysfunction in Parkinson’s disease. Semin Neurol. 2017;37(02):176–85 Thieme Medical Publishers.CrossRef
29.
go back to reference Zhao CY, Murrell DF. Advances in understanding and managing bullous pemphigoid. F1000Res. 2015;4:F1000 1–7. Zhao CY, Murrell DF. Advances in understanding and managing bullous pemphigoid. F1000Res. 2015;4:F1000 1–7.
30.
go back to reference Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJP, West J, et al. Bullous pemphigoid and pemphigus vulgaris—incidence and mortality in the UK: population based cohort study. BMJ. 2008;337:a180.CrossRef Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJP, West J, et al. Bullous pemphigoid and pemphigus vulgaris—incidence and mortality in the UK: population based cohort study. BMJ. 2008;337:a180.CrossRef
31.
go back to reference Joly P, Baricault S, Sparsa A, Bernard P, Bédane C, Duvert-Lehembre S, et al. Incidence and mortality of bullous pemphigoid in France. J Investig Dermatol. 2012;132(8):1998–2004.CrossRef Joly P, Baricault S, Sparsa A, Bernard P, Bédane C, Duvert-Lehembre S, et al. Incidence and mortality of bullous pemphigoid in France. J Investig Dermatol. 2012;132(8):1998–2004.CrossRef
32.
go back to reference Cordel N, Chosidow O, Hellot MF, Delaporte E, Lok C, Vaillant L, et al. Neurological disorders in patients with bullous pemphigoid. Dermatology. 2007;215:187–91.CrossRef Cordel N, Chosidow O, Hellot MF, Delaporte E, Lok C, Vaillant L, et al. Neurological disorders in patients with bullous pemphigoid. Dermatology. 2007;215:187–91.CrossRef
33.
go back to reference •• Brick KE, Weaver CH, Savica R, Lohse CM, Pittelkow MR, Boeve BF, et al. A population-based study of the association between bullous pemphigoid and neurologic disorders. J Am Acad Dermatol. 2014;71(6):1191–7 A case control and retrospective review which demonstrates a significantly increased risk of bullous pemphigoid development in those patients previously diagnosed with any type of neurological disorder. CrossRef •• Brick KE, Weaver CH, Savica R, Lohse CM, Pittelkow MR, Boeve BF, et al. A population-based study of the association between bullous pemphigoid and neurologic disorders. J Am Acad Dermatol. 2014;71(6):1191–7 A case control and retrospective review which demonstrates a significantly increased risk of bullous pemphigoid development in those patients previously diagnosed with any type of neurological disorder. CrossRef
34.
go back to reference Milani-Nejad N, Zhang M, Kaffenberger J. The association between bullous pemphigoid and neurological disorders: a systematic review. Eur J Dermatol. 2017;27(5):472–81.PubMed Milani-Nejad N, Zhang M, Kaffenberger J. The association between bullous pemphigoid and neurological disorders: a systematic review. Eur J Dermatol. 2017;27(5):472–81.PubMed
35.
go back to reference Chen J, Li L, Chen J, Zeng Y, Xu H, Song Y, et al. Sera of elderly bullous pemphigoid patients with associated neurological diseases recognize bullous pemphigoid antigens in the human brain. Gerontology. 2011;57(3):211–6.CrossRef Chen J, Li L, Chen J, Zeng Y, Xu H, Song Y, et al. Sera of elderly bullous pemphigoid patients with associated neurological diseases recognize bullous pemphigoid antigens in the human brain. Gerontology. 2011;57(3):211–6.CrossRef
36.
go back to reference Bastuji-Garin S, Joly P, Lemordant P, et al. Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Investig Dermatol. 2011;131:637–43.CrossRef Bastuji-Garin S, Joly P, Lemordant P, et al. Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Investig Dermatol. 2011;131:637–43.CrossRef
37.
go back to reference Tarazona MJM, Mota ANC de M, Gripp AC, Unterstell N, Bressan AL. Bullous pemphigoid and neurological disease: statistics from a dermatology service. An Bras Dermatol. 2015;90(2):280–2.CrossRef Tarazona MJM, Mota ANC de M, Gripp AC, Unterstell N, Bressan AL. Bullous pemphigoid and neurological disease: statistics from a dermatology service. An Bras Dermatol. 2015;90(2):280–2.CrossRef
38.
go back to reference •• Försti A-K, Jokelainen J, Ansakorpi H, et al. Psychiatric and neurological disorders are associated with bullous pemphigoid – a nationwide Finnish Care Register study. Sci Rep. 2016;6:37125 A nationwide Finnish retrospective review which demonstrates a nearly six times odds ratio increase of bullous pemphigoid development after diagnosis of multiple sclerosis. CrossRef •• Försti A-K, Jokelainen J, Ansakorpi H, et al. Psychiatric and neurological disorders are associated with bullous pemphigoid – a nationwide Finnish Care Register study. Sci Rep. 2016;6:37125 A nationwide Finnish retrospective review which demonstrates a nearly six times odds ratio increase of bullous pemphigoid development after diagnosis of multiple sclerosis. CrossRef
39.
go back to reference Rodríguez-Leyva I, Chi-Ahumada EG, Carrizales J, et al. Parkinson disease and progressive supranuclear palsy: protein expression in skin. Ann Clin Transl Neurol. 2016;3(3):191–9.CrossRef Rodríguez-Leyva I, Chi-Ahumada EG, Carrizales J, et al. Parkinson disease and progressive supranuclear palsy: protein expression in skin. Ann Clin Transl Neurol. 2016;3(3):191–9.CrossRef
40.
go back to reference Siepmann T, Penzlin AI, Illigens BM-W, Reichmann H. Should skin biopsies be performed in patients suspected of having Parkinson’s disease? Parkinsons Dis. 2017:1–6.CrossRef Siepmann T, Penzlin AI, Illigens BM-W, Reichmann H. Should skin biopsies be performed in patients suspected of having Parkinson’s disease? Parkinsons Dis. 2017:1–6.CrossRef
41.
go back to reference Langan SM, Groves RW, West J. The relationship between neurological disease and bullous pemphigoid: a population-based case–control study. J Investig Dermatol. 2011;131(3):631–6.CrossRef Langan SM, Groves RW, West J. The relationship between neurological disease and bullous pemphigoid: a population-based case–control study. J Investig Dermatol. 2011;131(3):631–6.CrossRef
Metadata
Title
Skin Disease and Neurological Conditions of the Elderly
Authors
John Tanaka
Christopher Henderson
Matilda W. Nicholas
Publication date
01-12-2018
Publisher
Springer US
Published in
Current Geriatrics Reports / Issue 4/2018
Electronic ISSN: 2196-7865
DOI
https://doi.org/10.1007/s13670-018-0263-z

Other articles of this Issue 4/2018

Current Geriatrics Reports 4/2018 Go to the issue

Physical Therapy and Rehabilitation (O Addison, Section Editor)

Distinguishing Comorbidity, Disability, and Frailty

Infectious Diseases in the Elderly (T Rowe, Section Editor)

Vaccinations for Older Adults

DERMATOLOGY AND WOUND CARE (C SAYED AND D CULTON, SECTION EDITORS)

Treatment of Non-melanoma Skin Cancer in the Elderly

Geriatric Orthopedics (E Meinberg, Section Editor)

Academic Geriatric Orthopedics: a New Paradigm for Inpatient Care